// App-Quantinova.ai

ISE.230 : Development of hepatocellular carcinoma in a HBeAg-negative chronic hepatitis B patient without cirrhosis under the long-term virological suppression with lamivudine plus adefovir therapy

Researchers

Presenter

  • E. Gunal

Principal Investigators

  • C. P. Eyigun

Medical Centers

  • Diyarbakir Military Hospital, Infectious Disease and Clinical Microbiology Service, Diyarbakir/TR,

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Hepatitis B

  • Cirrhosis

  • Solid malignancies

Biomarkers

  • Alpha-fetoprotein

Drug/Treatment

  • Alfa-fetoprotein

  • Lamivudine

  • Interferon

  • Adefovir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved